Activation of the C19MC miR-519d was shown to target CDKN1A/p21, PTEN, AKT3 and TIMP2, and is closely associated with the pathogenesis of hepatocellular carcinoma by promoting cell proliferation and invasion, and in inhibiting apoptosis [47]. This evidence concerns the gene CDKN1A and hepatocellular carcinoma.